A phase I trial of agalsidase-beta (ISU303) for the treatment of Fabry's-disease
Latest Information Update: 27 Apr 2015
At a glance
- Drugs Agalsidase beta (Primary)
- Indications Fabry's disease
- Focus Adverse reactions
Most Recent Events
- 27 Apr 2015 New trial record